{
  "paper_metadata": {
    "pmid": "30804345",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses two variants of the TTR gene: T119M and S52P, detailing their clinical significance, penetrance data, and functional effects."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.356C>T",
      "protein_notation": "p.Thr119Met",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": 1,
        "demographics": "heterozygous individuals",
        "phenotype": "asymptomatic of FAP or present a more benign form of the disease"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "asymptomatic of FAP",
          "evidence_sentence": "The T119M mutation is non-amyloidogenic, and heterozygous individuals carrying the T119M mutation and an amyloidogenic mutation, such as V30M, either remain asymptomatic of FAP or present a more benign form of the disease."
        }
      ],
      "functional_data": {
        "summary": "The T119M mutation stabilizes the dimer\u2013dimer interface as well as TTR\u2019s tertiary structure.",
        "assays": [
          "neutron crystallography",
          "mass spectrometry"
        ]
      },
      "segregation_data": "The T119M mutation is associated with a protective effect against FAP.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The T119M mutation is noted for its protective effects against amyloidosis.",
      "key_quotes": [
        "The T119M mutation is non-amyloidogenic, and heterozygous individuals carrying the T119M mutation and an amyloidogenic mutation, such as V30M, either remain asymptomatic of FAP or present a more benign form of the disease."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.155C>T",
      "protein_notation": "p.Ser52Pro",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "aggressive and early-onset fatal amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "aggressive and early-onset fatal amyloidosis",
          "evidence_sentence": "On the other hand, individuals carrying the S52P mutation develop aggressive and early-onset fatal amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "The S52P mutation destabilizes TTR by altering the stability of the CD loop in the protein monomer.",
        "assays": [
          "neutron crystallography",
          "mass spectrometry"
        ]
      },
      "segregation_data": "The S52P mutation is associated with familial amyloid polyneuropathy.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The S52P mutation is highly amyloidogenic and leads to severe disease manifestations.",
      "key_quotes": [
        "On the other hand, individuals carrying the S52P mutation develop aggressive and early-onset fatal amyloidosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}